Evidence map›Paper›PMID 33122734›Full record

ArticleScientific reports2020

Genotyping of methicillin resistant Staphylococcus aureus from the United Arab Emirates.

Abiola Senok, Rania Nassar, Handan Celiloglu, Anju Nabi, Mubarak Alfaresi, Stefan Weber, Irfan Rizvi, Elke Müller, Annett Reissig, Darius Gawlik and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Emergence of livestock-associated MRSA in the Egyptian Nile Delta that carry the exfoliative toxin gene etA: a case for enhanced surveillance.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  9. Mechanisms of fusidic acid resistance.Biochemical Society transactions · 2025
    Review
  10. Article
  11. Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Methicillin-resistantFrontiers in microbiology · 2025
    Article
  13. Molecular epidemiology of methicillin-resistantFrontiers in microbiology · 2025
    Review
  14. Article
  15. Article
  16. Sequencing a CC239-MRSA-III with a novel composite SCC mec element from Kuwait.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  17. Article
  18. Article
  19. Methicillin-ResistantMicroorganisms · 2023
    Article
  20. Community-Acquired Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Abiola SenokCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, P.O. Box 505055, Dubai, United Arab Emirates. abiola.senok@mbru.ac.ae.
Rania NassarCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, P.O. Box 505055, Dubai, United Arab Emirates.
Handan CelilogluCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, P.O. Box 505055, Dubai, United Arab Emirates.
Anju NabiMicrobiology & Infection Control Unit, Pathology Department, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates.
Mubarak AlfaresiCollege of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Stefan WeberReference Laboratory for Infectious Diseases, Shaikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Irfan RizviMicrobiology Department, Mediclinic City Hospital, Dubai Healthcare City, Dubai, United Arab Emirates.
Elke MüllerLeibniz Institute of Photonic Technology (IPHT), Jena, Germany.
Annett ReissigLeibniz Institute of Photonic Technology (IPHT), Jena, Germany.
Darius GawlikPTC - Phage Technology Center GmbH, Bönen, Germany.
Stefan MoneckeLeibniz Institute of Photonic Technology (IPHT), Jena, Germany.
Ralf EhrichtLeibniz Institute of Photonic Technology (IPHT), Jena, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reports from Arabian Gulf countries have demonstrated emergence of novel methicillin resistant Staphylococcus aureus (MRSA) strains. To address the lack of data from the United Arab Emirates (UAE), genetic characterisation of MRSA identified between December 2017 and August 2019 was conducted using DNA microarray-based assays. The 625 MRSA isolates studied were grouped into 23 clonal complexes (CCs) and assigned to 103 strains. CC5, CC6, CC22 and CC30 represented 54.2% (n/N = 339/625) of isolates with other common CCs being CC1, CC8, CC772, CC361, CC80, CC88. Emergence of CC398 MRSA, CC5-MRSA-IV Sri Lanka Clone and ST5/ST225-MRSA-II, Rhine-Hesse EMRSA/New York-Japan Clone in our setting was detected. Variants of pandemic CC8-MRSA-[IVa + ACME I] (PVL+) USA300 were detected and majority of CC772 strains were CC772-MRSA-V (PVL+), "Bengal- Bay Clone". Novel MRSA strains identified include CC5-MRSA-V (edinA+), CC5-MRSA-[VT + fusC], CC5-MRSA-IVa (tst1+), CC5-MRSA-[V/VT + cas + fusC + ccrA/B-1], CC8-MRSA-V/VT, CC22-MRSA-[IV + fusC + ccrAA/(C)], CC45-MRSA-[IV + fusC + tir], CC80-MRSA-IVa, CC121-MRSA-V/VT, CC152-MRSA-[V + fusC] (PVL+). Although several strains harboured SCC-borne fusidic acid resistance (fusC) (n = 181), erythromycin/clindamycin resistance (ermC) (n = 132) and gentamicin resistance (aacA-aphD) (n = 179) genes, none harboured vancomycin resistance genes while mupirocin resistance gene mupR (n = 2) and cfr gene (n = 1) were rare. An extensive MRSA repertoire including CCs previously unreported in the region and novel strains which probably arose locally suggest an evolving MRSA landscape.

Indexed as

Anti-Bacterial AgentsDNA, BacterialFusidic AcidGenotypeHumansJapanMethicillin-Resistant Staphylococcus aureusNew YorkSri LankaStaphylococcal InfectionsUnited Arab EmiratesVancomycinVirulence FactorsAnti-Bacterial AgentsDNA, BacterialFusidic AcidVancomycinVirulence Factors

Identifiers

PMID33122734
PMCPMC7596093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.